Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations

Abstract

A systems immunology approach established different immunologic profiles induced by current immunomodulatory MS treatments, offering perspectives for personalized medicine. Pathways shared between the immunologic architecture of existing efficacious treatments identify targets for future treatment design.